AIM VACCINE CO LTD
(HKEX: 6660)
AIM Vaccine Co., Ltd. engages in biological vaccine technology development, technology transfer, and technical services. Its products include Recombinant hepatitis B vaccine, Freeze-dried Human Rabies vaccine, Inactivated Hepatitis A vaccine, Live Attenuated Parotitis vaccine, Inactivated HFRS vaccine, and ACYW135 Meningococcus Polysaccharide vaccine. The company was founded on November 9, 2011 and is headquartered in Beijing, China.
6.380 -
+0.280
(+4.59%)
Range
6.100 - 6.810
(11.64%)
Open
6.100
Previous Close
6.100
Bid Price
6.380
Bid Volume
('000)
71.2
Ask Price
6.380
Ask Volume
('000)
34.4
Volume
('000)
6,106
Value
39,547,850
Remark
-
Delayed prices. Updated at 20 Dec 2024 15:59.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
